Imugene Ltd has released a press release.
Appendix 4E and Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Imugene
- Imugene Capital Raising Presentation
- Imugene Completes $22.5M Placement and c.$15M SPP
- Imugene Announces Outstanding Response Rates from the Phase 1b Trial of the Azer-cel Allogeneic CAR T in 3L+ DLBCL
- Two Additional Complete Responses in azer-cel Ph1b trial
- Notice of Extraordinary General Meeting/Proxy Form
Later from Imugene
- Final Share Purchase Plan Allotment
- S&P DJI Announces September 2025 Quarterly Rebalance
- Strategic Collaboration with JW Therapeutics
- Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours
- FDA Supports Strategy Toward Registration for Azer-cel
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene